CEACAM5 and colorectal carcinoma: Moreover, combined with anti‐p53 Abs, CEA, and CA19‐9, anti‐FIRΔexon2 Abs exhibited the highest AUC of 0.750 in sera of patients with CRC (Figure 3H).